INS and type 2 diabetes mellitus: Furthermore, the intermittent use of rtCGM in people with type 2 diabetes on oral anti-diabetic drugs, with or without basal insulin, is emerging as an effective strategy in lowering HbA1c in the short-term [31, 32].